JP2024521618A5 - - Google Patents
Info
- Publication number
- JP2024521618A5 JP2024521618A5 JP2023564563A JP2023564563A JP2024521618A5 JP 2024521618 A5 JP2024521618 A5 JP 2024521618A5 JP 2023564563 A JP2023564563 A JP 2023564563A JP 2023564563 A JP2023564563 A JP 2023564563A JP 2024521618 A5 JP2024521618 A5 JP 2024521618A5
- Authority
- JP
- Japan
- Prior art keywords
- heptan
- azaspiro
- methanone
- triazole
- cyclopropyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21170090 | 2021-04-23 | ||
| EP21170090.1 | 2021-04-23 | ||
| CNPCT/CN2022/083125 | 2022-03-25 | ||
| CN2022083125 | 2022-03-25 | ||
| PCT/EP2022/060644 WO2022223750A1 (en) | 2021-04-23 | 2022-04-22 | Heterocyclic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024521618A JP2024521618A (ja) | 2024-06-04 |
| JP2024521618A5 true JP2024521618A5 (enExample) | 2025-04-22 |
Family
ID=81750728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564563A Pending JP2024521618A (ja) | 2021-04-23 | 2022-04-22 | 複素環式化合物 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20240199587A1 (enExample) |
| EP (1) | EP4326714A1 (enExample) |
| JP (1) | JP2024521618A (enExample) |
| KR (1) | KR20240000574A (enExample) |
| CN (1) | CN117295726A (enExample) |
| AR (1) | AR125401A1 (enExample) |
| AU (1) | AU2022260537A1 (enExample) |
| CA (1) | CA3215260A1 (enExample) |
| CL (1) | CL2023003154A1 (enExample) |
| CO (1) | CO2023014721A2 (enExample) |
| CR (1) | CR20230496A (enExample) |
| IL (1) | IL306126A (enExample) |
| MX (1) | MX2023012477A (enExample) |
| PE (1) | PE20240239A1 (enExample) |
| TW (1) | TW202309010A (enExample) |
| WO (1) | WO2022223750A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20211089A1 (es) | 2018-08-13 | 2021-06-14 | Hoffmann La Roche | Nuevos compuestos heterociclicos como inhibidores de la monoacilglicerol lipasa |
| WO2020104494A1 (en) | 2018-11-22 | 2020-05-28 | F. Hoffmann-La Roche Ag | New heterocyclic compounds |
| WO2023130050A1 (en) * | 2021-12-29 | 2023-07-06 | Psy Therapeutics, Inc. | Monoacylglycerol lipase inhibitors and use thereof for the treatment and management of pain |
| CA3242372A1 (en) * | 2021-12-29 | 2023-07-06 | Psy Therapeutics, Inc. | Inhibiting monoacylglycerol lipase (magl) |
| US20250170100A1 (en) * | 2021-12-29 | 2025-05-29 | Psy Therapeutics, Inc. | Monoacylglycerol lipase inhibitors and use thereof for the treatment of anxiety and related conditions |
| KR20240139073A (ko) * | 2022-01-25 | 2024-09-20 | 에프. 호프만-라 로슈 아게 | 신규 헤테로고리 화합물 |
| EP4543870A1 (en) * | 2022-06-24 | 2025-04-30 | F. Hoffmann-La Roche AG | New heterocyclic-carbonyl-cyclic compounds as magl inhibitors |
| IL318647A (en) | 2022-08-05 | 2025-03-01 | Kumquat Biosciences Inc | Heterocyclic compounds and their uses |
| WO2024215863A2 (en) * | 2023-04-13 | 2024-10-17 | Psy Therapeutics, Inc. | Inhibiting monoacylglycerol lipase (magl) |
| WO2025010394A2 (en) * | 2023-07-06 | 2025-01-09 | Psy Therapeutics, Inc. | Monoacylglycerol lipase inhibitors and use thereof for the treatment and management of inflammatory conditions |
| WO2025010392A2 (en) * | 2023-07-06 | 2025-01-09 | Psy Therapeutics, Inc. | Monoacylglycerol lipase inhibitors and use thereof for the treatment of neurological disorders |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3204383B1 (en) * | 2014-10-08 | 2020-11-18 | F.Hoffmann-La Roche Ag | Spirodiamine derivatives as aldosterone synthase inhibitors |
| BR112017028318B1 (pt) * | 2015-07-02 | 2024-02-20 | Janssen Sciences Ireland Uc | Composto antibacteriano, seu uso, processo para sua preparação,produto que o contém, composição farmacêutica e combinação |
| EP3679043B9 (en) * | 2017-09-05 | 2023-09-27 | Neumora Therapeutics, Inc. | Vasopressin receptor antagonists and products and methods related thereto |
| EP3758695A4 (en) * | 2018-02-28 | 2021-10-06 | The Trustees Of The University Of Pennsylvania | POLY (AD-RIBOSE) -POLYMERASE 1 DEPENDENT CYTOTOXIC AGENTS WITH LOW AFFINITY |
| JP2021522253A (ja) * | 2018-04-25 | 2021-08-30 | ユマニティ セラピューティクス，インコーポレーテッド | 化合物及びその使用 |
| WO2020104494A1 (en) * | 2018-11-22 | 2020-05-28 | F. Hoffmann-La Roche Ag | New heterocyclic compounds |
| CN111793064B (zh) * | 2019-04-02 | 2023-06-23 | 上海美悦生物科技发展有限公司 | 一种作为irak抑制剂的化合物及其制备方法和用途 |
| MX2023003240A (es) * | 2020-09-22 | 2023-06-16 | Janssen Pharmaceutica Nv | Moduladores de monoacilglicerol lipasa de ciclobutilamida. |
-
2022
- 2022-04-22 CN CN202280030020.6A patent/CN117295726A/zh active Pending
- 2022-04-22 WO PCT/EP2022/060644 patent/WO2022223750A1/en not_active Ceased
- 2022-04-22 TW TW111115346A patent/TW202309010A/zh unknown
- 2022-04-22 AU AU2022260537A patent/AU2022260537A1/en active Pending
- 2022-04-22 AR ARP220101039A patent/AR125401A1/es unknown
- 2022-04-22 PE PE2023002921A patent/PE20240239A1/es unknown
- 2022-04-22 EP EP22724696.4A patent/EP4326714A1/en active Pending
- 2022-04-22 MX MX2023012477A patent/MX2023012477A/es unknown
- 2022-04-22 JP JP2023564563A patent/JP2024521618A/ja active Pending
- 2022-04-22 KR KR1020237040339A patent/KR20240000574A/ko active Pending
- 2022-04-22 CR CR20230496A patent/CR20230496A/es unknown
- 2022-04-22 CA CA3215260A patent/CA3215260A1/en active Pending
- 2022-04-22 IL IL306126A patent/IL306126A/en unknown
-
2023
- 2023-10-20 US US18/490,967 patent/US20240199587A1/en active Pending
- 2023-10-20 CL CL2023003154A patent/CL2023003154A1/es unknown
- 2023-10-30 CO CONC2023/0014721A patent/CO2023014721A2/es unknown